Maria Meißner, Eva Steinke, Mark Oliver Wielpütz, Cornelia Joachim, Olaf Sommerburg, Marcus Alexander Mall, Mirjam Stahl
{"title":"重新分析氮气多次呼吸冲洗对囊性纤维化临床稳定期和肺部恶化期儿童胸部磁共振成像结果关系的影响。","authors":"Maria Meißner, Eva Steinke, Mark Oliver Wielpütz, Cornelia Joachim, Olaf Sommerburg, Marcus Alexander Mall, Mirjam Stahl","doi":"10.1055/a-2214-7217","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Multiple-breath washout (MBW)-derived lung clearance index (LCI) detects lung disease in children with cystic fibrosis (CF). Correction of a cross-talk error in the software of the MBW device Exhalyzer D in a new software version has generated significant interest regarding its impact on previous MBW findings. Since LCI and chest magnetic resonance imaging (MRI) correlated before in CF children, this study aims to reassess previous MBW data after correction.</p><p><strong>Patients/methods: </strong>Reanalysis of the main findings from a previously published study comparing MBW and MRI in a pediatric CF cohort by reassessment of nitrogen (N<sub>2</sub>) MBW of 61 stable children with CF, 75 age-matched healthy controls (HC), and 15 CF children with pulmonary exacerbation (PEx) in the corrected software version.</p><p><strong>Results: </strong>The corrected LCI (N<sub>2</sub>LCI<sub>cor</sub>) decreased in the entire cohort (-17.0 (11.2)%), HC (-8.5 (8.2)%), stable CF children (-22.2 (11.1)%), and within the PEx group at baseline, at PEx and after antibiotic therapy (-21.5 (7.3)%; -22.5 (6.1)%; -21.4 (6.6)%; all P<0.01). N<sub>2</sub>LCI<sub>cor</sub> and N<sub>2</sub>LCI<sub>pre</sub> correlated with chest MRI scores in stable CF (r=0.70 to 0.84; all P<0.01) without a significant difference between N<sub>2</sub>LCI<sub>cor</sub> and N<sub>2</sub>LCI<sub>pre</sub>. Change in LCI from baseline to PEx and from PEx to after therapy decreased from N<sub>2</sub>LCI<sub>pre</sub> to N<sub>2</sub>LCI<sub>cor</sub>, but these changes remained significant (all P=0.001).</p><p><strong>Discussion/conclusions: </strong>Our results indicate that N<sub>2</sub>LCI<sub>cor</sub> is significantly lower than N<sub>2</sub>LCI<sub>pre</sub>, but key results published in the original study demonstrating N<sub>2</sub>MBW and MRI as complementary methods for clinical surveillance in children with CF remain unaffected.</p>","PeriodicalId":17846,"journal":{"name":"Klinische Padiatrie","volume":" ","pages":"106-115"},"PeriodicalIF":1.2000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Reanalysis of Nitrogen Multiple-Breath Washout on its Relationship with Chest Magnetic Resonance Imaging Findings in Clinically Stable and Pulmonary Exacerbated Children with Cystic Fibrosis.\",\"authors\":\"Maria Meißner, Eva Steinke, Mark Oliver Wielpütz, Cornelia Joachim, Olaf Sommerburg, Marcus Alexander Mall, Mirjam Stahl\",\"doi\":\"10.1055/a-2214-7217\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>Multiple-breath washout (MBW)-derived lung clearance index (LCI) detects lung disease in children with cystic fibrosis (CF). Correction of a cross-talk error in the software of the MBW device Exhalyzer D in a new software version has generated significant interest regarding its impact on previous MBW findings. Since LCI and chest magnetic resonance imaging (MRI) correlated before in CF children, this study aims to reassess previous MBW data after correction.</p><p><strong>Patients/methods: </strong>Reanalysis of the main findings from a previously published study comparing MBW and MRI in a pediatric CF cohort by reassessment of nitrogen (N<sub>2</sub>) MBW of 61 stable children with CF, 75 age-matched healthy controls (HC), and 15 CF children with pulmonary exacerbation (PEx) in the corrected software version.</p><p><strong>Results: </strong>The corrected LCI (N<sub>2</sub>LCI<sub>cor</sub>) decreased in the entire cohort (-17.0 (11.2)%), HC (-8.5 (8.2)%), stable CF children (-22.2 (11.1)%), and within the PEx group at baseline, at PEx and after antibiotic therapy (-21.5 (7.3)%; -22.5 (6.1)%; -21.4 (6.6)%; all P<0.01). N<sub>2</sub>LCI<sub>cor</sub> and N<sub>2</sub>LCI<sub>pre</sub> correlated with chest MRI scores in stable CF (r=0.70 to 0.84; all P<0.01) without a significant difference between N<sub>2</sub>LCI<sub>cor</sub> and N<sub>2</sub>LCI<sub>pre</sub>. Change in LCI from baseline to PEx and from PEx to after therapy decreased from N<sub>2</sub>LCI<sub>pre</sub> to N<sub>2</sub>LCI<sub>cor</sub>, but these changes remained significant (all P=0.001).</p><p><strong>Discussion/conclusions: </strong>Our results indicate that N<sub>2</sub>LCI<sub>cor</sub> is significantly lower than N<sub>2</sub>LCI<sub>pre</sub>, but key results published in the original study demonstrating N<sub>2</sub>MBW and MRI as complementary methods for clinical surveillance in children with CF remain unaffected.</p>\",\"PeriodicalId\":17846,\"journal\":{\"name\":\"Klinische Padiatrie\",\"volume\":\" \",\"pages\":\"106-115\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinische Padiatrie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2214-7217\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/12/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinische Padiatrie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2214-7217","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
Impact of Reanalysis of Nitrogen Multiple-Breath Washout on its Relationship with Chest Magnetic Resonance Imaging Findings in Clinically Stable and Pulmonary Exacerbated Children with Cystic Fibrosis.
Rationale: Multiple-breath washout (MBW)-derived lung clearance index (LCI) detects lung disease in children with cystic fibrosis (CF). Correction of a cross-talk error in the software of the MBW device Exhalyzer D in a new software version has generated significant interest regarding its impact on previous MBW findings. Since LCI and chest magnetic resonance imaging (MRI) correlated before in CF children, this study aims to reassess previous MBW data after correction.
Patients/methods: Reanalysis of the main findings from a previously published study comparing MBW and MRI in a pediatric CF cohort by reassessment of nitrogen (N2) MBW of 61 stable children with CF, 75 age-matched healthy controls (HC), and 15 CF children with pulmonary exacerbation (PEx) in the corrected software version.
Results: The corrected LCI (N2LCIcor) decreased in the entire cohort (-17.0 (11.2)%), HC (-8.5 (8.2)%), stable CF children (-22.2 (11.1)%), and within the PEx group at baseline, at PEx and after antibiotic therapy (-21.5 (7.3)%; -22.5 (6.1)%; -21.4 (6.6)%; all P<0.01). N2LCIcor and N2LCIpre correlated with chest MRI scores in stable CF (r=0.70 to 0.84; all P<0.01) without a significant difference between N2LCIcor and N2LCIpre. Change in LCI from baseline to PEx and from PEx to after therapy decreased from N2LCIpre to N2LCIcor, but these changes remained significant (all P=0.001).
Discussion/conclusions: Our results indicate that N2LCIcor is significantly lower than N2LCIpre, but key results published in the original study demonstrating N2MBW and MRI as complementary methods for clinical surveillance in children with CF remain unaffected.
期刊介绍:
Das Forum für wissenschaftliche Information in der Kinderheilkunde
ausgewählte Originalarbeiten aus allen Bereichen der Pädiatrie
Visite: Ihr Forum für interessante Krankengeschichten und außergewöhnliche Kasuistiken
aktuelle Fortschritte in Diagnostik und Therapie
jährliche Schwerpunkthefte: Ergebnisse der pädiatrischen Onkologie
plus Medizin und Markt
topaktuelle Informationen aus der Industrie